Anti-Influenza A Virus Hemagglutinin HA2 Subunit Recombinant Antibody

Product Information

Catalog Number	YR1335
Product Name	Anti-Influenza A Virus Hemagglutinin HA2 Subunit Recombinant Antibody
Molecular Name	Diridavumab
Alias	Anti-Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains Recombinant Antibody, Research Grade Diridavumab
CAS Number	1393659-46-5
Target	Influenza A Virus Hemagglutinin HA2 Subunit from Various Strains[Influenza A Virus]
Isotype	IgG1 Lambda
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	FCM
Buffer	PBS, pH7.5
Background	Diridavumab (CR6261) (INN) is a monoclonal antibody designed for the treatment of influenza A. This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price